Acute Ischemic Stroke Diagnosis and Treatment Market Report 2024 (Global Edition)

Global Acute Ischemic Stroke Diagnosis and Treatment Market Report 2024 Market Size Split by Diagnostics Technology (Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angio...

Acute Ischemic Stroke Diagnosis and Treatment Market Report Description

We have various report editions of Acute Ischemic Stroke Diagnosis and Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Acute Ischemic Stroke Diagnosis and Treatment Market Insights Video

Competitive Landscape of the Acute Ischemic Stroke Diagnosis and Treatment Market

The competitive landscape of the Acute Ischemic Stroke Diagnosis and Treatment market is characterized by a range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established medical device manufacturers, specialized Acute Ischemic Stroke Diagnosis and Treatment companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

February 2022: CERENOVUS, one of the up-and-coming leaders in neurovascular care and a division of Johnson & Johnson Medical Devices Companies, introduced EMBOGUARD, a next-generation balloon guide catheter intended for use in endovascular treatments, particularly those for patients suffering from acute ischemic stroke. (Source: https://www.jnjmedtech.com/en-US/news-events/cerenovus-launches-emboguard-balloon-guide-catheter-use-treatment-acute-ischemic) October 2021: The pRESET 6-50 mechanical thrombectomy device, designed to treat acute large vascular occlusive (LVO) stroke, is another addition to Phenox's vast technology portfolio. (Source:https://phenox.net/international/news/phenox-announces-expansion-of-their-technology-portfolio-for-ais-with-the-global-launch-of-the-preset-6-50-thrombectomy-device/)

Top Companies Market Share in Acute Ischemic Stroke Diagnosis and Treatment Industry: (In no particular order of Rank)

• GE Healthcare
• F. Hoffmann-La Roche Ltd.
• Koninklijke Philips N.V.
• Johnson & Johnson
• Medtronic plc
• Siemens
• Abbott Laboratories
• AstraZeneca plc
• Stryker Corporation.
• Boehringer Ingelheim International GmbH
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Acute Ischemic Stroke Diagnosis and Treatment Market

Which Region Dominates the Acute Ischemic Stroke Diagnosis and Treatment Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. Because of supporting government programs, advances in technology, and rising ischemic stroke product demand. In addition, major market participants are concentrating on implementing inorganic growth tactics, such as partnerships and acquisitions, to broaden their product offerings and establish a stronger position in the worldwide acute ischemic stroke (AIS) market. For example, the global biopharmaceutical company AstraZeneca announced in November 2020 the launch of Brilinta, an oral, reversible, direct-acting P2Y12 receptor antagonist. Brilinta is used to reduce the risk of stroke in individuals suffering from an acute ischemic stroke or high-risk transient ischemic attack (TIA). One of the main reasons people get disabled and die from strokes is worldwide. Furthermore, the rising incidence of stroke in North America propels market expansion. In the United States in 2019, cardiovascular disease (CVD) was identified as the primary cause of death, accounting for 874,613 fatalities, according to the American Heart Association 2022. Furthermore, according to Dawn O. Kleindorfer's May 2021 article in the American Heart Association Journal, 795,000 Americans get a stroke each year, of which 87% (690,000) are ischemic, and 185,000 are recurrent. More than 240,000 persons experience transient ischemic attacks (TIAs) annually. The market for acute ischemic stroke diagnostics and treatment is therefore anticipated to expand due to the increase in cardiovascular disease cases and stroke in this country.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Acute Ischemic Stroke Diagnosis and Treatment market. Because of its large and aging population, which puts it at increased risk for stroke, Asia Pacific is expected to drive significant growth in the industry of acute ischemic stroke diagnosis and therapy. Stroke-related risk factors, like diabetes and hypertension, have increased in the area due to rapid urbanization and lifestyle changes. The area is also seeing increases in healthcare spending, better access to cutting-edge diagnostic and treatment options, and improvements in the infrastructure supporting healthcare. Asia-Pacific is a key development region for the stroke market due to government initiatives focused on improving stroke care and raising awareness.

The current report Scope analyzes Acute Ischemic Stroke Diagnosis and Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Acute Ischemic Stroke Diagnosis and Treatment Market

According to Cognitive Market Research, the global Acute Ischemic Stroke Diagnosis and Treatment market size was estimated at USD 5521.5 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2208.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Acute Ischemic Stroke Diagnosis and Treatment market with a market size of USD 1742.59 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. The incidence of stroke is on the rise because of factors like a growing elderly population and rising rates of risk factors like obesity, diabetes, and hypertension.
• The Canada Acute Ischemic Stroke Diagnosis and Treatment market had a market share of USD 265.03 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. Stroke care is supported by the Canadian government's emphasis on chronic illness management and healthcare.
• The Mexico Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 200.98 million in 2024.

Europe Acute Ischemic Stroke Diagnosis and Treatment Market

According to Cognitive Market Research, the global Acute Ischemic Stroke Diagnosis and Treatment market size was estimated at USD 5521.5 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 1656.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.

• The United Kingdom Acute Ischemic Stroke Diagnosis and Treatment market had a market share of USD 278.28 million in 2024 and is projected to grow at a CAGR of 6.1% during the forecast period. The adoption of cutting-edge modalities of treatment and imaging enhances the results of stroke care.
• The France Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 152.39 million in 2024.
• According to Cognitive Market Research, the German Acute Ischemic Stroke Diagnosis and Treatment market size was valued at USD 327.98 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Stroke services are in high demand due to the emphasis on patient-centered care and rehabilitation.
• The Italy Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 142.45 million in 2024.
• The Russian Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 256.75 million in 2024.
• The Spain Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 4.4% during the forecast period with a market size of USD 135.83 million in 2024
• The Luxembourg Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 51.35 million in 2024.
• The Portugal Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 34.79 million in 2024.
• The Greece Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 19.88 million in 2024.
• Rest of Europe's Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 256.75 million in 2024.

Asia Pacific Acute Ischemic Stroke Diagnosis and Treatment Market

According to Cognitive Market Research, the global Acute Ischemic Stroke Diagnosis and Treatment market size was estimated at USD 5521.5 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1269.95 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Acute Ischemic Stroke Diagnosis and Treatment market size was valued at USD 571.48 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. In China, timely care is becoming more accessible due to the growth of healthcare facilities, such as specialized stroke units.
• The Japan Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 175.25 million in 2024.
• The India Acute Ischemic Stroke Diagnosis and Treatment market had a market share of USD 152.39 million in 2024 and is projected to grow at a CAGR of 10.6% during the forecast period. The number of stroke cases is rising as a result of rapid urbanization and associated lifestyle changes.
• The South Korean Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 126.99 million in 2024.
• The Australian Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 66.04 million in 2024.
• The South East Asia Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 87.63 million in 2024.
• The Rest of the Asia Pacific Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 90.17 million in 2024.

South America Acute Ischemic Stroke Diagnosis and Treatment Market

According to Cognitive Market Research, the global Acute Ischemic Stroke Diagnosis and Treatment market size was estimated at USD 5521.5 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 276.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Acute Ischemic Stroke Diagnosis and Treatment market size was valued at USD 118.16 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. The need for cutting-edge therapies and rehabilitation services is being driven by an increasing emphasis on enhancing the outcomes for stroke patients.
• Argentina's Acute Ischemic Stroke Diagnosis and Treatment market had a market share of USD 46.38 million in 2024 and is projected to grow at a CAGR of 7.1% during the forecast period. A growing middle class with more disposable income to spend is fueling the need for high-quality medical care.
• Colombia's Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 24.57 million in 2024.
• Peru's Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 22.64 million in 2024.
• Chile's Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 19.88 million in 2024.
• The Rest of Latin America's Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 44.45 million in 2024.

Middle East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market

According to Cognitive Market Research, the global Acute Ischemic Stroke Diagnosis and Treatment market size was estimated at USD 5521.5 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 110.43 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031..

• The GCC Countries Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 47.26 million in 2024. The focus on stroke prevention and treatment has expanded as non-communicable diseases have gained more attention.
• The Egypt Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 11.60 million in 2024.
• The South African Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 17.45 million in 2024. The industry is expanding as a result of government initiatives aimed at disease prevention and control, such as efforts to raise awareness of stroke.
• The Turkey Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 9.50 million in 2024.
• The Nigeria Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 11.60 million in 2024.
• The Rest of the MEA Acute Ischemic Stroke Diagnosis and Treatment market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 13.03 million in 2024.

Acute Ischemic Stroke Diagnosis and Treatment Market Analysis

Acute Ischemic Stroke Diagnosis and Treatment Market Diagnostics Technology Segment Analysis

According to Cognitive Market Research, Magnetic Resonance Imaging stands out as the dominant category over the projected period. The use of magnetic resonance imaging (MRI) is necessary for precise and thorough brain imaging in the acute ischemic stroke diagnosis and treatment market. MRI is used to identify between hemorrhagic and ischemic strokes, visualize brain tissue, and gauge the degree of ischemic damage. With the use of its sophisticated imaging capabilities, stroke site and severity may be precisely determined, treatment planning is guided, and recovery progress can be tracked. The capacity of MRI to produce high-resolution pictures improves the precision of diagnosis and helps guide efficient stroke care.

Computed Tomography emerges as the fastest-growing category in the Acute Ischemic Stroke Diagnosis and Treatment market. Computed tomography (CT) is a frequently utilized imaging modality for the brain that is rapid and reliable in the acute ischemic stroke diagnosis and treatment market. Detecting hemorrhagic strokes, making treatment options, and assessing strokes at the outset all depend on CT scans. They aid with ischemia localization, differential diagnosis, and treatment efficacy tracking. CT technology plays a crucial role in providing prompt and accurate patient care by enabling the quick detection and treatment of acute ischemic stroke.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Acute Ischemic Stroke Diagnosis and Treatment Industry. Request a Free Sample PDF!

Acute Ischemic Stroke Diagnosis and Treatment Market Treatment Segment Analysis

According to Cognitive Market Research, the dominant category is Thrombolytic Therapy. Thrombolytic therapy is in great demand in the acute ischemic stroke diagnosis and treatment market because of its efficiency in breaking up blood clots and reestablishing blood flow to the brain. If given within a certain time frame after the stroke's beginning, this medication is essential for reducing brain damage and enhancing results. The rising acceptance of this therapy, which is an essential part of acute stroke management, is driven by the expanding understanding of early stroke intervention and the developments in thrombolytic drugs.

The fastest-growing category in the Acute Ischemic Stroke Diagnosis and Treatment market is Mechanical Thrombectomy. The demand for mechanical thrombectomy in the acute ischemic stroke diagnosis and treatment market is increasing because of its capacity to remove significant blood clots from the brain's arteries, restoring blood flow and minimizing stroke-related damage. Patients with severe strokes are increasingly being advised to have this treatment, particularly when thrombolytic therapy is also being used. The adoption of thrombectomy therapy is being driven by improvements in thrombectomy devices and mounting clinical evidence of its efficacy, making it an essential tool in the care of acute strokes.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Acute Ischemic Stroke Diagnosis and Treatment End User Segment Analysis

Acute Ischemic Stroke Diagnosis and Treatment Market End User Segment Analysis

According to Cognitive Market Research, the dominant category is Hospitals and Clinics. Clinics and hospitals are essential in delivering acute and emergency care, making them important end users in the acute ischemic stroke diagnosis and treatment market. In addition to providing specialist care like mechanical thrombectomy and thrombolytic therapy, these institutions are outfitted with cutting-edge diagnostic devices like CT and MRI scanners. The ability of hospitals and clinics to provide timely, all-inclusive care, improving patient outcomes and improving stroke management, is what drives the need for stroke care services.

The fastest-growing category in the Acute Ischemic Stroke Diagnosis and Treatment market is Ambulatory Surgery Centers. Because of their emphasis on offering specialized outpatient operations, ambulatory surgery centers (ASCs) are gaining importance as end users in the acute ischemic stroke diagnosis and treatment market. ASCs provide a variety of stroke therapies in an efficient and economical setting, such as mechanical thrombectomy. The usage of ASCs for acute stroke care is being driven by the increased need for minimally invasive procedures and faster recovery times. This allows patients to receive treatment sooner while also lowering hospital stays and related expenses.

• Hospitals and Clinics
• Ambulatory Surgery Centers
• Diagnostic Laboratories and Imaging Centers
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion